Interpore Cross
This article was originally published in The Gray Sheet
Executive Summary
Spinal implant maker will acquire AOM-CDO system for placing reinforcing substances inside bony structures such as spinal vertebrae through a $21.3 mil. agreement with privately held OsteoMedix, announced May 31. Introduced in mid-2000, the minimally invasive device allows treatment of pain from vertebral compression fractures, according to Interpore. Expected to close by July 31, the deal calls for Interpore to pay $8 mil. in cash and about $2.4 mil. in Interpore stock, which closed May 30 at $5.53 per share. AOM had about $1.2 mil. in sales in 2000
You may also be interested in...
Interpore’s $30 Mil. Spinal Business Provides Backbone For Growth
Interpore Cross International's C-TEK anterior cervical plate and Synergy lower back and deformity systems are driving a big jump in the company's spinal product line: sales of spinal products climbed 49% to $8.4 mil. in the final quarter of 2001
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.